Tetracycline and Amphotericin B

Phase 3Small molecule

Tetracycline and Amphotericin B is one of 19 small molecule programs targeting Bacterial Vaginosis. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Bacterial VaginosisActive, not recruiting

Bacterial VaginosisPhase 3

Active, not recruiting

Competition

Competitive Landscape

65 competitors in Bacterial Vaginosis

#DrugCompanyPhaseTrials

Acanya

Pfizer

Approved

3 2

Decadron

AAspen Global Incorporated

Approved

—3

Amoxil

GGlobal Antibiotics Research and Development Partnership

Mycostatin

Lactobacillus Acidophilus

UUniversiteit Antwerpen

Approved

1 6

Tindamax

MMission Pharmacal

Phase 3

3 7

Conventional

PPopulation Health Research Institute

Phase 3

1 8

Lactoferrin

UUniversità degli Studi di Ferrara

Phase 3

1 9

Lactoserum

Sanofi

Approved

1 10

Xifaxan

SSalix

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Bacterial Vaginosis1 trial

Evaluate Efficacy, Tolerability & Safety of Combination of Clindamycin and Ketoconazole for the Treatment of Mixed-Type Vaginosis, Bacterial Vaginosis and Candidiasis

Unknown status·ZZodiac Produtos Farmaceuticos S.A.·Phase 3·NCT00889356·160 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Tetracycline and Amphotericin B. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Tetracycline and Amphotericin B compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Tetracycline and Amphotericin B. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Zodiac Produtos Farmaceuticos S.A. company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: ZZodiac Produtos Farmaceuticos S.A.

Tetracycline and Amphotericin B

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Bacterial Vaginosis1 trial

References

Drug Info

Quick Facts

Related News